A citation-based method for searching scientific literature

Csaba Nyakas, Klára Felszeghy, Róbert Szabó, Jan N Keijser, Paul G M Luiten, Zsolt Szombathelyi, Károly Tihanyi. CNS Neurosci Ther 2009
Times Cited: 31







List of co-cited articles
308 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Role of sodium channel inhibition in neuroprotection: effect of vinpocetine.
P Bönöczk, B Gulyás, V Adam-Vizi, A Nemes, E Kárpáti, B Kiss, M Kapás, C Szántay, I Koncz, T Zelles,[...]. Brain Res Bull 2000
97
22

Vinpocetine inhibits NF-kappaB-dependent inflammation via an IKK-dependent but PDE-independent mechanism.
Kye-Im Jeon, Xiangbin Xu, Toru Aizawa, Jae Hyang Lim, Hirofumi Jono, Dong-Seok Kwon, Jun-Ichi Abe, Bradford C Berk, Jian-Dong Li, Chen Yan. Proc Natl Acad Sci U S A 2010
155
22


Effects of vinpocetine on the redistribution of cerebral blood flow and glucose metabolism in chronic ischemic stroke patients: a PET study.
Géza Szilágyi, Zoltán Nagy, László Balkay, István Boros, Miklós Emri, Szabolcs Lehel, Teréz Márián, Tamás Molnár, Szabolcs Szakáll, Lajos Trón,[...]. J Neurol Sci 2005
36
19


Eburnamine derivatives and the brain.
Adám Vas, Balázs Gulyás. Med Res Rev 2005
61
16

Cerebral effects of a single dose of intravenous vinpocetine in chronic stroke patients: a PET study.
S Szakáll, I Boros, L Balkay, M Emri, I Fekete, L Kerényi, S Lehel, T Márián, T Molnár, J Varga,[...]. J Neuroimaging 1998
42
16

Brain uptake and plasma metabolism of [11C]vinpocetine: a preliminary PET study in a cynomolgus monkey.
B Gulyás, C Halldin, P Karlsson, Y H Chou, C G Swahn, P Bönöck, M Paróczai, L Farde. J Neuroimaging 1999
34
16



Effects of Vinpocetine on mitochondrial function and neuroprotection in primary cortical neurons.
K Tárnok, E Kiss, P G M Luiten, C Nyakas, K Tihanyi, K Schlett, U L M Eisel. Neurochem Int 2008
21
19

Effect of parenteral or oral vinpocetine on the hemorheological parameters of patients with chronic cerebrovascular diseases.
Gergely Feher, Katalin Koltai, Gabor Kesmarky, Beata Horvath, Kalman Toth, Samuel Komoly, Laszlo Szapary. Phytomedicine 2009
7
57


Synaptosomal response to oxidative stress: effect of vinpocetine.
M S Santos, A I Duarte, P I Moreira, C R Oliveira. Free Radic Res 2000
41
12

Ethyl apovincaminate therapy in neurovascular diseases.
A Szobor, M Klein. Arzneimittelforschung 1976
36
12


Ginsenosides: are any of them candidates for drugs acting on the central nervous system?
Seung-Yeol Nah, Dong-Hyun Kim, Hyewhon Rhim. CNS Drug Rev 2007
124
12


Inhibitory activity on amyloid-beta aggregation and antioxidant properties of Crocus sativus stigmas extract and its crocin constituents.
Magdalini A Papandreou, Charalambos D Kanakis, Moschos G Polissiou, Spyros Efthimiopoulos, Paul Cordopatis, Marigoula Margarity, Fotini N Lamari. J Agric Food Chem 2006
188
12

Vinpocetine for cognitive impairment and dementia.
S Z Szatmari, P J Whitehouse. Cochrane Database Syst Rev 2003
57
12

A 22-week, multicenter, randomized, double-blind controlled trial of Crocus sativus in the treatment of mild-to-moderate Alzheimer's disease.
Shahin Akhondzadeh, Mehdi Shafiee Sabet, Mohammad Hossein Harirchian, Mansoreh Togha, Hamed Cheraghmakani, Soodeh Razeghi, Seyyed Shamssedin Hejazi, Mohammad Hossein Yousefi, Roozbeh Alimardani, Amirhossein Jamshidi,[...]. Psychopharmacology (Berl) 2010
122
12

Salvia for dementia therapy: review of pharmacological activity and pilot tolerability clinical trial.
Nicolette S L Perry, Chloe Bollen, Elaine K Perry, Clive Ballard. Pharmacol Biochem Behav 2003
144
12


Vincamine and vincanol are potent blockers of voltage-gated Na+ channels.
S A Erdo, P Molnár, V Lakics, J Z Bence, Z Tömösközi. Eur J Pharmacol 1996
26
15

The spice sage and its active ingredient rosmarinic acid protect PC12 cells from amyloid-beta peptide-induced neurotoxicity.
Teresa Iuvone, Daniele De Filippis, Giuseppe Esposito, Alessandra D'Amico, Angelo A Izzo. J Pharmacol Exp Ther 2006
149
12




Clinical and non-clinical investigations using positron emission tomography, near infrared spectroscopy and transcranial Doppler methods on the neuroprotective drug vinpocetine: a summary of evidences.
Adám Vas, Balázs Gulyás, Zsolt Szabó, Péter Bönöczk, László Csiba, Béla Kiss, Egon Kárpáti, Gyula Pánczél, Zoltán Nagy. J Neurol Sci 2002
21
14


PET studies on the brain uptake and regional distribution of [11C]vinpocetine in human subjects.
B Gulyás, C Halldin, J Sandell, P Karlsson, J Sóvágó, E Kárpáti, B Kiss, A Vas, Z Cselényi, L Farde. Acta Neurol Scand 2002
45
9

The safety and lack of efficacy of vinpocetine in Alzheimer's disease.
L J Thal, D P Salmon, B Lasker, D Bower, M R Klauber. J Am Geriatr Soc 1989
41
9


A systematic review of vinpocetine therapy in acute ischaemic stroke.
D Bereczki, I Fekete. Eur J Clin Pharmacol 1999
24
12

Cannabidiol, a Cannabis sativa constituent, as an antipsychotic drug.
A W Zuardi, J A S Crippa, J E C Hallak, F A Moreira, F S Guimarães. Braz J Med Biol Res 2006
241
9


Cytotoxicity of Vinca minor.
Mahnaz Khanavi, Shabnam Pourmoslemi, Behnaz Farahanikia, Abbas Hadjiakhoondi, Seyed Nasser Ostad. Pharm Biol 2010
13
23

Curry consumption and cognitive function in the elderly.
Tze-Pin Ng, Peak-Chiang Chiam, Theresa Lee, Hong-Choon Chua, Leslie Lim, Ee-Heok Kua. Am J Epidemiol 2006
192
9

In-vitro activity of S. lavandulaefolia (Spanish sage) relevant to treatment of Alzheimer's disease.
N S Perry, P J Houghton, J Sampson, A E Theobald, S Hart, M Lis-Balchin, J R Hoult, P Evans, P Jenner, S Milligan,[...]. J Pharm Pharmacol 2001
81
9


A double-blind placebo-controlled randomized trial of Melissa officinalis oil and donepezil for the treatment of agitation in Alzheimer's disease.
Alistair Burns, Elaine Perry, Clive Holmes, Paul Francis, Julie Morris, Melanie-Jayne R Howes, Paul Chazot, George Lees, Clive Ballard. Dement Geriatr Cogn Disord 2011
64
9

Pharmacological profile of an essential oil derived from Melissa officinalis with anti-agitation properties: focus on ligand-gated channels.
Sawsan Abuhamdah, Liping Huang, Mark S J Elliott, Melanie-Jayne R Howes, Clive Ballard, Clive Holmes, Alistair Burns, Elaine K Perry, Paul T Francis, George Lees,[...]. J Pharm Pharmacol 2008
22
13

Benefits of combining donepezil plus traditional Japanese herbal medicine on cognition and brain perfusion in Alzheimer's disease: a 12-week observer-blind, donepezil monotherapy controlled trial.
Masahiro Maruyama, Naoko Tomita, Koh Iwasaki, Mari Ootsuki, Toshifumi Matsui, Miyako Nemoto, Nobuyuki Okamura, Makoto Higuchi, Miho Tsutsui, Tomoko Suzuki,[...]. J Am Geriatr Soc 2006
29
10

Cannabidiol for the treatment of psychosis in Parkinson's disease.
A W Zuardi, J A S Crippa, J E C Hallak, J P Pinto, M H N Chagas, G G R Rodrigues, S M Dursun, V Tumas. J Psychopharmacol 2009
169
9

Six-month randomized, placebo-controlled, double-blind, pilot clinical trial of curcumin in patients with Alzheimer disease.
Larry Baum, Christopher Wai Kei Lam, Stanley Kwok-Kuen Cheung, Timothy Kwok, Victor Lui, Joshua Tsoh, Linda Lam, Vivian Leung, Elsie Hui, Chelsia Ng,[...]. J Clin Psychopharmacol 2008
341
9

Salvia lavandulaefolia (Spanish sage) enhances memory in healthy young volunteers.
N T J Tildesley, D O Kennedy, E K Perry, C G Ballard, S Savelev, K A Wesnes, A B Scholey. Pharmacol Biochem Behav 2003
77
9


Naturally occurring phytochemicals for the prevention of Alzheimer's disease.
Jiyoung Kim, Hyong Joo Lee, Ki Won Lee. J Neurochem 2010
200
9


Cholinesterase inhibitors reduce cortical Abeta in dementia with Lewy bodies.
C G Ballard, K A Chalmers, C Todd, I G McKeith, J T O'Brien, G Wilcock, S Love, E K Perry. Neurology 2007
54
9


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.